Physician

Adam C Reynolds, M.D.

According to 2025 Medicare claims, Adam Reynolds, M.D. (NPI: 1417916586) practices ophthalmology in the Boise City, ID market, with the plurality of this provider's patient population coming from Ada, ID. This provider's primary affiliated billing organization is INTERMOUNTAIN EYE AND LASER CENTERS PLLC (NPI: 1730119611; TIN: 820482491) and primary practice location at 83706-1316.

Reynolds' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,126 traditional Medicare patients, billed 3,851 HCPCS/CPT codes, and received $287,962 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 7,883 prescription claims across 1,478 beneficiaries totaling $744,373 in drug costs, led by Rocklatan (Netarsudil Mesylat/Latanoprost). 2023 DME data shows 11 claims. Open Payments data shows 12 records totaling $1,824. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $446,850 to $744,373. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,480	4,325	$377,071
2016	1,485	4,225	$368,938
2017	1,508	4,679	$372,621
2018	1,500	4,768	$367,667
2019	1,483	4,994	$380,728
2020	1,133	3,828	$257,992
2021	1,288	4,670	$348,949
2022	1,181	4,290	$314,589
2023	1,186	4,354	$324,229
2024	1,126	3,851	$287,962

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,067	5,530	$446,850
2016	1,131	5,993	$481,412
2017	1,234	6,609	$544,015
2018	1,275	6,778	$646,040
2019	1,373	7,047	$776,780
2020	1,297	6,956	$837,081
2021	1,407	7,626	$878,747
2022	1,468	8,352	$956,391
2023	1,501	8,452	$964,081
2024	1,478	7,883	$744,373

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	44	44	$3,500
2016	27	27	$1,904
2017	27	27	$1,791
2018	37	37	$2,712
2019	41	43	$3,632
2020	33	33	$2,689
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	11	11	$1,376
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	735	736	$75
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	190	231	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	575	846	$56
92083	Exam of visual field with extended testing	588	806	$40
92133	Imaging of optic nerve	522	548	$23

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rocklatan	Netarsudil Mesylat/Latanoprost	237	14,477	$179,135
Rhopressa	Netarsudil Mesylate	160	9,342	$98,572
Lumigan	Bimatoprost	121	7,484	$70,542
Restasis	Cyclosporine	31	2,310	$46,216
Vyzulta	Latanoprostene Bunod	67	4,638	$38,675

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$1,824	Alcon Research LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam C. Reynolds, M.D.?

Tedicare shows public-source Medicare data for Adam C. Reynolds, M.D. (NPI 1417916586), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam C. Reynolds, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam C. Reynolds, M.D.?

Adam C. Reynolds, M.D. is linked to INTERMOUNTAIN EYE AND LASER CENTERS PLLC (billing NPI 1730119611) in the available physician profile data.

Does Adam C. Reynolds, M.D. have Open Payments data?

Adam C. Reynolds, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.